Structural insights into anion selectivity and activation mechanism of LRRC8 volume-regulated anion channels.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
29 08 2023
Historique:
received: 29 12 2022
revised: 12 06 2023
accepted: 18 07 2023
medline: 4 9 2023
pubmed: 6 8 2023
entrez: 6 8 2023
Statut: ppublish

Résumé

Volume-regulated anion channels (VRACs) are hexamers of LRRC8 proteins that are crucial for cell volume regulation. N termini (NTs) of the obligatory LRRC8A subunit modulate VRACs activation and ion selectivity, but the underlying mechanisms remain poorly understood. Here, we report a 2.8-Å cryo-electron microscopy structure of human LRRC8A that displays well-resolved NTs. Amino-terminal halves of NTs fold back into the pore and constrict the permeation path, thereby determining ion selectivity together with an extracellular selectivity filter with which it works in series. They also interact with pore-surrounding helices and support their compact arrangement. The C-terminal halves of NTs interact with intracellular loops that are crucial for channel activation. Molecular dynamics simulations indicate that low ionic strength increases NT mobility and expands the radial distance between pore-surrounding helices. Our work suggests an unusual pore architecture with two selectivity filters in series and a mechanism for VRAC activation by cell swelling.

Identifiants

pubmed: 37543949
pii: S2211-1247(23)00937-3
doi: 10.1016/j.celrep.2023.112926
pmc: PMC10480491
pii:
doi:

Substances chimiques

Membrane Proteins 0
Anions 0
LRRC8A protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112926

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Nature. 2018 Dec;564(7736):372-377
pubmed: 30542154
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Elife. 2018 Aug 10;7:
pubmed: 30095067
Nat Struct Mol Biol. 2018 Sep;25(9):797-804
pubmed: 30127360
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C293-C303
pubmed: 33356947
Nat Methods. 2012 Sep;9(9):853-4
pubmed: 22842542
J Biol Chem. 2018 Aug 31;293(35):13440-13451
pubmed: 29925591
EMBO J. 2015 Dec 14;34(24):2993-3008
pubmed: 26530471
Biophys J. 1993 Dec;65(6):2455-60
pubmed: 7508762
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5298-303
pubmed: 10220460
FEBS Lett. 2004 Oct 22;576(3):433-6
pubmed: 15498575
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Cell. 2016 Jan 28;164(3):499-511
pubmed: 26824658
J Biol Chem. 2016 Aug 12;291(33):17040-8
pubmed: 27325695
J Biol Chem. 2002 Jun 7;277(23):20812-9
pubmed: 11923294
Science. 2014 May 9;344(6184):634-8
pubmed: 24790029
Curr Opin Struct Biol. 2022 Jun;74:102382
pubmed: 35504105
Biophys J. 2016 Oct 4;111(7):1429-1443
pubmed: 27705766
Am J Physiol. 1998 Aug;275(2):C416-22
pubmed: 9688595
Nature. 2002 Jan 17;415(6869):287-94
pubmed: 11796999
Nature. 2018 Jun;558(7709):254-259
pubmed: 29769723
Biochim Biophys Acta. 2016 Apr;1858(4):740-7
pubmed: 26779604
J Mol Biol. 2003 Oct 31;333(4):721-45
pubmed: 14568533
Elife. 2023 Mar 10;12:
pubmed: 36897307
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
J Cell Sci. 2017 Mar 15;130(6):1122-1133
pubmed: 28193731
Front Pharmacol. 2022 May 11;13:896532
pubmed: 35645818
Cell Physiol Biochem. 2021 Feb 13;55(S1):41-56
pubmed: 33577730
Nat Rev Mol Cell Biol. 2016 May;17(5):293-307
pubmed: 27033257
Nat Struct Mol Biol. 2023 Jan;30(1):52-61
pubmed: 36522427
J Physiol. 2022 Sep;600(17):3965-3982
pubmed: 35861288
Biophys J. 2022 Apr 5;121(7):1336-1347
pubmed: 35151630
J Phys Chem B. 2020 Nov 19;124(46):10326-10336
pubmed: 33147018
Ultramicroscopy. 2013 Dec;135:24-35
pubmed: 23872039
Biophys J. 1999 Oct;77(4):1753-68
pubmed: 10512801
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Commun Biol. 2020 May 15;3(1):240
pubmed: 32415200
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Elife. 2019 Jun 18;8:
pubmed: 31210638
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Br J Pharmacol. 1999 Sep;128(1):35-40
pubmed: 10498832
J Gen Physiol. 2019 Feb 4;151(2):100-117
pubmed: 30651298
J Gen Physiol. 2018 Jul 2;150(7):1003-1015
pubmed: 29853476
Nat Commun. 2016 Dec 01;7:13681
pubmed: 27905396
Elife. 2019 Feb 18;8:
pubmed: 30775971
J Chem Phys. 2020 Oct 7;153(13):134110
pubmed: 33032406
J Mol Biol. 2021 Aug 20;433(17):166994
pubmed: 33865869
Cell. 2014 Apr 10;157(2):447-458
pubmed: 24725410
Nature. 2009 Apr 2;458(7238):597-602
pubmed: 19340074
Nat Commun. 2021 Sep 14;12(1):5435
pubmed: 34521847
Sci Signal. 2022 Feb 8;15(720):eabg6941
pubmed: 35133866
Acta Physiol (Oxf). 2015 Apr;213(4):868-81
pubmed: 25565132
Nat Struct Mol Biol. 2023 Jun;30(6):841-852
pubmed: 36928458
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Prog Biophys Mol Biol. 1997;68(1):69-119
pubmed: 9481145
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13419-24
pubmed: 12370423
Biophys J. 2012 Mar 21;102(6):1363-71
pubmed: 22455919
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
Nat Protoc. 2014 Nov;9(11):2574-85
pubmed: 25299155
J Comput Chem. 2013 Sep 30;34(25):2135-45
pubmed: 23832629
Nature. 2020 Aug;584(7822):646-651
pubmed: 32494015
Bioessays. 2012 Jul;34(7):551-60
pubmed: 22532330
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Heng Liu (H)

School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Maya M Polovitskaya (MM)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Max-Delbrück-Centrum für Molekulare Medizin (MDC), 13125 Berlin, Germany.

Linlin Yang (L)

Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 45001, China. Electronic address: yanglin-89@zzu.edu.cn.

Meiling Li (M)

Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 45001, China.

Hongyue Li (H)

School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Zhen Han (Z)

Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 45001, China.

Jianguo Wu (J)

School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Qiansen Zhang (Q)

Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China. Electronic address: qszhang@bio.ecnu.edu.cn.

Thomas J Jentsch (TJ)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Max-Delbrück-Centrum für Molekulare Medizin (MDC), 13125 Berlin, Germany; Cluster of Excellence NeuroCure, Charité Universitätsmedizin Berlin, Berlin, Germany. Electronic address: jentsch@fmp-berlin.de.

Jun Liao (J)

School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: liaojun@shanghaitech.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH